(Q28571669)

31 January 2017

title

Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells (English)

1 reference

31 January 2017

0 references

0 references

1 reference

0 references

Sigalit Nahman

1

1 reference

31 January 2017

R. H. Belmaker

series ordinal

2

1 reference

31 January 2017

Abed N. Azab

series ordinal

3

1 reference

31 January 2017

language of work or name

1 reference

1 June 2012

1 reference

31 January 2017

1 reference

31 January 2017

volume

18

1 reference

31 January 2017

issue

3

1 reference

31 January 2017

page(s)

447–458

1 reference

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1177/1753425911421512

A molecular mechanism for the effect of lithium on development

21 April 2017

1 reference

https://api.crossref.org/works/10.1177/1753425911421512

Bipolar disorder and mechanisms of action of mood stabilizers

21 April 2017

1 reference

https://api.crossref.org/works/10.1177/1753425911421512

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 April 2017

1 reference

https://api.crossref.org/works/10.1177/1753425911421512

Nitric oxide synthases in mammals

21 April 2017

1 reference

https://api.crossref.org/works/10.1177/1753425911421512

Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain

21 April 2017

1 reference

https://api.crossref.org/works/10.1177/1753425911421512

Neuroscience: Glia — more than just brain glue

21 April 2017

1 reference

https://api.crossref.org/works/10.1177/1753425911421512

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 April 2017

2 references

https://api.crossref.org/works/10.1177/1753425911421512

21 April 2017

https://api.crossref.org/works/10.1177%2F1753425911421512

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

21 April 2017

1 reference

https://api.crossref.org/works/10.1177/1753425911421512

Inositol phosphates and cell signalling

21 April 2017

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 April 2017

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Cyclooxygenases: structural, cellular, and molecular biology

21 April 2017

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Lithium specificity in bipolar illness: a classic agent for the classic disorder

21 April 2017

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Lithium, a potential protective drug in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Lithium delays progression of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Lithium and the kidney: an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Immunologic variables in acute mania of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Depression, inflammation, and cardiovascular disease: is 5-lipoxygenase the missing link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Coxibs and Alzheimer's disease: should they stay or should they go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Inflammation as a causative factor in the aetiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Selective COX-2 inhibitors: is the water becoming muddy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Novel non-steroidal anti-inflammatory drugs: what we have learned from animal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Nitric oxide, cell bioenergetics and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Effects of antidepressants on cytokine production and actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Immune and inflammatory responses in the CNS: modulation by astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Microglia: a sensor for pathological events in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Time-dependent effect of LPS on PGE2 and TNF-alpha production by rat glial brain culture: influence of COX and cytokine inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Effects of estrogen against LPS-induced inflammation and toxicity in primary rat glial and neuronal cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Depressive disorders and immunity: 20 years of progress and discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512

Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425911421512